Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS

Company research

American Well Corp

CIK 1393584Updated Oct 3, 2026

SecurityAMWL · NYSE · equity

AMWL price & chart

Provider market data

Loading TradingView…

NYSE:AMWL on TradingView ↗

TradingView · Data may be delayed

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. 144 filing

    144 · 2026-10-01 · 0001193125-26-410841

  2. 4 filing

    4 · 2026-09-03 · 0001193125-26-382079

  3. 4 filing

    4 · 2026-09-03 · 0001193125-26-382072

  4. 144 filing

    144 · 2026-09-01 · 0001193125-26-378641

  5. 10-Q filing

    10-Q · 2026-08-04 · 0001393584-26-000018

Show 5 more recent filings

  1. Results of Operations and Financial Condition

    Items 2.02, 9.01

    8-K · 2026-08-04 · 0001393584-26-000016

  2. Changes in Registrant's Certifying Accountant

    Items 4.01, 9.01

    8-K · 2026-07-21 · 0001193125-26-309112

  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

    Items 5.02

    8-K · 2026-07-14 · 0001193125-26-303282

  4. 144 filing

    144 · 2026-07-01 · 0001193125-26-292747

  5. Submission of Matters to a Vote of Security Holders

    Items 5.07

    8-K · 2026-06-22 · 0001193125-26-277605

Financials

FY 2025 · USD
Revenue249,325,000USD · FY 2025
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

Net income-95,700,000USD · FY 2025
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

Operating income-105,274,000USD · FY 2025
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

Diluted EPS-5.96USD per share · FY 2025
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD323,787,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

435,968,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

589,705,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,217,557,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Property, Plant and Equipment, NetUSD225,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

376,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

572,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,012,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

GoodwillUSD—0
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

0
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

435,279,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Intangible Assets, Net (Excluding Goodwill)USD66,073,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

101,538,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

120,248,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

134,980,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD182,328,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

228,316,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

372,038,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

538,546,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD49,693,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

71,885,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

54,146,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

58,372,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Inventory, NetUSD1,187,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

2,858,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

6,652,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

8,737,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Assets, CurrentUSD246,681,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

316,993,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

449,582,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

626,616,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD10,813,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

11,421,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

14,484,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

19,567,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD3,930,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

7,203,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

10,453,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

13,509,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Other Assets, NoncurrentUSD1,624,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

2,213,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

2,083,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,972,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD75,999,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

119,724,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

109,519,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

133,706,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD165,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

156,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

2,879,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

2,766,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Additional Paid in CapitalUSD2,309,145,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

2,286,380,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

2,234,768,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

2,160,108,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-2,061,628,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

-1,965,924,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

-1,757,778,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

-1,082,028,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-12,099,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

-15,840,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

-15,650,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

-16,969,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD235,583,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

304,772,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

464,219,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,063,877,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Liabilities and EquityUSD323,787,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

435,968,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

589,705,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,217,557,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD73,214,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

111,263,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

93,797,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

114,056,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Operating Lease, Liability, CurrentUSD3,632,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

3,690,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

3,580,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

3,057,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Accounts Payable, CurrentUSD1,649,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

5,015,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

4,864,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

7,236,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD892,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

4,511,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

8,206,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

11,787,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Other Liabilities, NoncurrentUSD1,075,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

1,170,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

1,425,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,574,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD12,205,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

11,472,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

15,967,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

19,974,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD45,308,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

49,326,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

38,988,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

54,258,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Deferred Tax Liabilities, NetUSD—1,024,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

1,298,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

1,460,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Dividends PayableUSD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

0
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

0
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD-94,967,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-212,638,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-679,171,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-272,072,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD33,960,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

32,973,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

31,512,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

26,167,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD22,010,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

47,542,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

72,246,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

67,675,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD-12,220,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

25,012,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-3,248,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

8,140,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Increase (Decrease) in InventoriesUSD-1,171,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-1,901,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2,085,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

1,207,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts PayableUSD-3,418,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

159,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2,361,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-4,780,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD-1,065,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-251,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-158,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

3,214,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD-65,953,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-127,338,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-148,343,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-192,323,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD17,104,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-18,652,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-19,168,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-11,630,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD21,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

119,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

192,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

292,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD840,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

1,381,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

2,147,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-3,612,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD-45,988,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-143,722,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-166,508,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-207,870,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD183,123,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

229,111,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

372,833,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

539,341,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Additional Financial Items
Accretion ExpenseUSD———793,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, ExpenseUSD21,930,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

47,505,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

72,040,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

69,144,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Amortization of Intangible AssetsUSD33,773,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

32,660,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

30,861,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

24,638,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Capitalized Computer Software, AmortizationUSD———0
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD8,634,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

———
Dividends PayableUSD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

As of 2025-12-31

0
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

0
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

—
Equity Method Investment, Other than Temporary ImpairmentUSD1,000,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD88,045,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

121,174,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

126,645,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

146,353,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

GoodwillUSD—0
Source

10-K · 2025-02-12 · 0000950170-25-019024

As of 2024-12-31

0
Source

10-K · 2024-02-15 · 0000950170-24-015995

As of 2023-12-31

435,279,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

As of 2022-12-31

Goodwill, Impairment LossUSD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

436,479,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Impairment of Intangible Assets (Excluding Goodwill)USD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

—
Income (Loss) from Equity Method InvestmentsUSD-1,696,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-3,110,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2,590,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-2,278,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD434,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

2,751,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

3,860,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

64,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Inventory Write-downUSD500,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

1,893,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

——
Net Income (Loss) Attributable to ParentUSD-95,700,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-208,143,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-675,164,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-270,429,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD733,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-4,495,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-4,007,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-1,643,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Operating Costs and ExpensesUSD354,599,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

471,898,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

951,190,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

553,043,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD4,077,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

3,746,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

4,292,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

4,967,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Payments to Acquire InvestmentsUSD1,000,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

—389,990,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

499,223,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

—569,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

5,740,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Total RevenueUSD249,325,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

254,364,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

259,047,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

277,190,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Operating Income (Loss)USD-105,274,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-217,534,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-692,143,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-275,853,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-94,533,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

——-269,730,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD434,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

2,751,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

3,860,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

64,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD733,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-4,495,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-4,007,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-1,643,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD-95,700,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-208,143,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-675,164,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-270,429,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share-5.96
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-13.88
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2.38
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-0.99
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share-5.96
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-13.88
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2.38
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-0.99
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares16,047,452
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

14,999,590
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

284,256,743
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

274,249,749
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares16,047,452
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

14,999,590
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

284,256,743
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

274,249,749
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Additional Financial Items
Amortization of Intangible AssetsUSD33,773,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

32,660,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

30,861,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

24,638,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Capitalized Computer Software, AmortizationUSD———0
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD116,467,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

155,412,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

164,287,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

160,422,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Current Income Tax Expense (Benefit)USD1,499,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

3,002,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

4,018,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-3,278,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Depreciation, Depletion and Amortization, NonproductionUSD33,961,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

32,975,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

31,492,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

26,153,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD88,045,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

121,174,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

126,645,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

146,353,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Goodwill, Impairment LossUSD0
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

436,479,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD-90,710,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

———
Income (Loss) from Equity Method InvestmentsUSD-1,696,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

-3,110,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

-2,590,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

-2,278,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Interest Income (Expense), NetUSD5,171,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

11,770,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

——
Interest Income (Expense), Nonoperating, NetUSD3,803,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

10,757,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

19,422,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

6,123,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Operating Costs and ExpensesUSD354,599,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

471,898,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

951,190,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

553,043,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD4,077,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

3,746,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

4,292,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

4,967,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD72,861,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

86,065,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

105,827,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

138,487,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Selling and Marketing ExpenseUSD43,265,000
Source

10-K · 2026-02-12 · 0001193125-26-048776

2025-01-01 to 2025-12-31

76,272,000
Source

10-K · 2025-02-12 · 0000950170-25-019024

2024-01-01 to 2024-12-31

86,460,000
Source

10-K · 2024-02-15 · 0000950170-24-015995

2023-01-01 to 2023-12-31

81,628,000
Source

10-K · 2023-02-23 · 0000950170-23-003945

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

amwl-ex99_1.htm · 8-K · 2026-08-04

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026 BOSTON, August 4, 2026 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026. “The DHA’s intent to make Amwell a prime contractor is a powerful endorsement of our platform and our people,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell. “With…

8-K · 2026-08-04 · 0001393584-26-000016

Read attachment ↗
amwl-ex99_1.htm · 8-K · 2026-05-05

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR FIRST QUARTER 2026 BOSTON, May 5, 2026 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended Mar. 31, 2026. “Entering 2026, Amwell’s main focus was to consolidate our platform to fulfill the unmet needs of our Payer and Provider customers. The Technology-Enabled Care infrastructure we …

8-K · 2026-05-05 · 0001193125-26-206427

Read attachment ↗
amwl-ex99_1.htm · 8-K · 2026-02-12

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR Fourth QUARTER AND FULL YEAR 2025 BOSTON, Feb. 12, 2026 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2025. "In 2025, we sharpened our focus on our Technology Enabled Care platform, which addresses clear and urgent unmet needs across Government, Payer, a…

8-K · 2026-02-12 · 0001193125-26-048737

Read attachment ↗
amwl-ex99_1.htm · 8-K · 2025-11-04

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Amwell® Announces Results for the Third Quarter Ended September 30, 2025 BOSTON - November 4, 2025 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter of 2025. “Our third quarter performance surpassed guidance and reflects continued execution of our strategic plan to reach break-even cash flow from operations by year-e…

8-K · 2025-11-04 · 0001193125-25-264710

Read attachment ↗
amwl-ex99_1.htm · 8-K · 2025-08-05

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Amwell® Announces Results for the Second Quarter Ended June 30, 2025 BOSTON - August 5, 2025 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter of 2025. “In Q2, we pursued our strategic initiatives with focus and strong execution. We added Florida Blue, an innovative, large health plan, to our list of strategic clien…

8-K · 2025-08-05 · 0000950170-25-103029

Read attachment ↗
amwl-ex99_1.htm · 8-K · 2025-05-01

EX-99.1 2 amwl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Amwell® Announces Results for the First Quarter Ended March 31, 2025 BOSTON - May 1, 2025 - Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter of 2025. “We had a strong Q1 across all our strategic initiatives. Together with our Leidos partners, we advanced our progress in the staged launch of our full solution across th…

8-K · 2025-05-01 · 0000950170-25-061838

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.